ADDvise Group Strengthens Financial Position with New Bond Issuance and Tender Offer

May 21, 2025, 6:03 pm
Mangold Fondkommission
Mangold Fondkommission
BrokerCorporateFinTechGrowthInvestmentManagementMarketMedTechResearchService
Location: Sweden, Stockholm
Employees: 51-200
Founded date: 2000
Nordea
Nordea
BusinessFinTechHomeInsurTechITManagementMarketPersonalProductService
Location: Finland, Mainland Finland, Helsinki
Employees: 10001+
Founded date: 1820
ADDvise Group AB
BusinessEquipmentHealthTechIndustryLabMedTechProductResearchServiceSupply
Location: Sweden, Stockholm
Employees: 201-500
Founded date: 1989
Total raised: $6.61M
In a strategic move to bolster its financial foundation, ADDvise Group AB has successfully issued new senior unsecured bonds worth SEK 800 million. This decision, announced on May 19, 2025, is part of a broader framework allowing for SEK 1.6 billion in total bond issuance. The bonds, set to mature in 3.5 years, will carry a floating interest rate of STIBOR 3m plus 3.50 percent per annum. The settlement date for this bond issue is anticipated to be May 28, 2025.

The demand for these new bonds was robust, attracting a diverse array of Nordic and international institutional investors. This reflects a strong vote of confidence in ADDvise’s business model and future prospects. The CEO expressed satisfaction with the outcome, highlighting the importance of an efficient capital structure and strengthened cash flow.

In conjunction with the bond issuance, ADDvise also initiated a tender offer for its existing senior secured bonds. This offer, which was announced on May 14, 2025, aimed to repurchase SEK 1,450 million of bonds due in 2026 and USD 60 million of bonds due in 2027. The tender offer closed on May 20, 2025, with a purchase price set at 102.278 percent for the 2026 bonds and 105.182 percent for the 2027 bonds, plus accrued interest.

The results of the tender offer were significant. ADDvise accepted SEK 588.75 million of the 2026 bonds and USD 40.125 million of the 2027 bonds for repurchase. The settlement for these transactions is also expected to occur on May 28, 2025, aligning with the issuance of the new bonds. This synchronization underscores ADDvise’s strategic planning and financial acumen.

Nordea Bank Abp played a pivotal role in these transactions, acting as the sole arranger and bookrunner for the new bond issuance, as well as the dealer manager and tender agent for the tender offer. Legal advice was provided by Gernandt & Danielsson, ensuring compliance and smooth execution of the financial maneuvers.

ADDvise Group operates within the life sciences sector, focusing on high-quality companies in the Lab and Healthcare domains. With a decentralized ownership model, the company comprises over 20 subsidiaries and generates annual revenues nearing SEK 1.7 billion. This diverse portfolio positions ADDvise well within a competitive market, allowing for growth and innovation.

The bond issuance and tender offer are not just financial maneuvers; they are strategic steps towards a more resilient future. By refinancing existing debt and securing new capital, ADDvise is laying the groundwork for continued expansion and investment in its core business areas. The strong interest from investors indicates a belief in ADDvise’s long-term strategy and operational effectiveness.

In a world where financial stability is paramount, ADDvise’s actions reflect a proactive approach. The company is not merely reacting to market conditions; it is shaping its destiny. By optimizing its capital structure, ADDvise is ensuring that it can weather economic storms and seize opportunities as they arise.

The life sciences sector is ever-evolving, and companies must adapt to remain relevant. ADDvise’s commitment to developing and acquiring high-quality companies is a testament to its forward-thinking strategy. The new bonds will provide the necessary capital to fuel this growth, enabling the company to invest in innovation and enhance its service offerings.

As the settlement date approaches, stakeholders will be watching closely. The successful execution of these financial strategies could set a precedent for future endeavors. Investors are keen to see how ADDvise will leverage this new capital to drive growth and enhance shareholder value.

In conclusion, ADDvise Group’s recent bond issuance and tender offer represent a significant step in its financial journey. By securing new funding and optimizing its existing debt, the company is positioning itself for future success. The strong demand for the new bonds is a clear signal of investor confidence. As ADDvise continues to navigate the complexities of the life sciences market, its strategic financial decisions will play a crucial role in shaping its future. The road ahead is promising, and ADDvise is ready to seize the opportunities that lie ahead.